
CIZZLE BRANDS CORPORATION
US$15,150,000
3,030,000 Common Shares
US$5.00 per Common Share
This offering (the "Offering") is the initial underwritten public offering of common shares (the "Common Shares") of Cizzle Brands Corporation (the "Company", "Cizzle", "us", "we" or "our"). This prospectus supplement (the "Prospectus Supplement") together with the short form base shelf prospectus dated October 7, 2025 (the "Shelf Prospectus") relates to the distribution in the United States of 3,030,000 Common Shares (the "Offered Shares") on a post-Share Consolidation (as defined below) basis at a price of US$5.00 per Offered Share (the "Offering Price"), for aggregate gross proceeds to the Company of US$15,150,000.
The Offering is being made in the United States under the terms of the Company's registration statement on Form F-10 (the "Registration Statement") filed with the United States Securities and Exchange Commission (the "SEC") under the multijurisdictional disclosure system adopted in the United States and Canada. No Common Shares will be offered under this Prospectus Supplement in Canada, and this Prospectus Supplement does not qualify the distribution of the Offered Shares in Canada.
As part of the Offering, the Underwriter may arrange for purchasers in each of the provinces and territories of Canada, to purchase Common Shares directly from the Company as substituted purchasers for aggregate gross proceeds of US$8,887,500 (approximately C$12,724,234) pursuant to the exemption from the prospectus requirement set out in Part 5A of National Instrument 45-106 – Prospectus Exemptions, as modified by Coordinated Blanket Order 45-935 – Exemptions from Certain Conditions of the Listed Issuer Financing Exemption (collectively, the "LIFE Exemption"). 1,777,500 Common Shares will be sold pursuant to the LIFE Exemption. Sales made pursuant to the LIFE Exemption will be made through the Underwriter's Canadian registered dealer affiliates or other Canadian registered selling firms.
Investing in the Common Shares involves significant risk. Prospective investors should consider the risk factors described under "Risk Factors" and "Cautionary Note Regarding Forward-Looking Statements" and in the documents incorporated by reference in this Prospectus Supplement and the Shelf Prospectus.
Our Common Shares are listed and posted for trading on Cboe Canada Inc. (the "Cboe Canada") under the symbol "CZZL" and trade in the United States on the OTCQB under the symbol "CZZLF". We have applied to list the Common Shares offered hereunder on The Nasdaq Stock Market ("Nasdaq") under the symbol "CZZL". Listing is subject to our fulfilling all of the listing requirements of Nasdaq. On November 19, 2026, the last trading day prior to the date of this Prospectus Supplement, the closing price of the Common Shares (prior to giving effect to the Share Consolidation) on Cboe Canada was C$0.33 and on the OTCQB was US$0.2124.
Price: US$5.00 per Common Share
Price to the public(1)(2)
Underwriter's commission(4)
Net proceeds to the Company(3)
Per Common Share
US$5.00
US$0.325
US$4.675
Total Offering(5)
US$15,150,000
US$984,750
US$14,165,250
(1) The Offering Price is payable in United States dollars, except as may otherwise be agreed to by the Underwriter.
(2) The Offering Price was determined by negotiation between us and the Underwriter with reference to the market price of the Common Shares.
(3) After deducting the Underwriter's commission equal to 6.5% of the gross proceeds of the Offering payable by the Company, but before deducting the expenses of the Offering (including the Underwriter's non-accountable expense allowance equal to 1.0% of the gross proceeds of the Offering (the "Expense Allowance"), estimated to be approximately US$713,216, which expenses will be paid by the Company out of the proceeds of the Offering. See "Plan of Distribution".
(4) Assumes that no Offered Shares are sold to purchasers on the Company's president's list, in respect of which the Underwriter's commission is reduced to 3.75%, and that no Offered Shares are issued in respect of which no commission is payable
(5) The Company has granted the Underwriter the right to purchase up to an additional 15% of the Offered Shares (454,500 additional Common Shares) (the "Additional Shares") at a public offering price equal to the Offering Price. The Underwriter may exercise this right at any time, in whole or in part, within 45 days following the Closing Date (the "Option to Purchase Additional Shares"). If the Option to Purchase Additional Shares is exercised in full, the total "Price to the public", "Underwriter's commission" and "Net proceeds to the Company" will be approximately US$17,422,500, US$1,132,462.50 and US$16,290,037.50, respectively. See "Plan of Distribution".
The following table sets out the number of Common Shares that may be sold to the Underwriter pursuant to the Option to Purchase Additional Shares.
Underwriter's position
Maximum number of Common Shares available
Exercise period
Exercise price
Option to Purchase Additional Shares
454,500 Additional Shares
Within 45 days following the Closing Date
Offering Price (US$5.00 per Additional Share)
All dollar amounts in this Prospectus Supplement are in United States dollars, unless otherwise indicated. See "Currency and Exchange Rate Information".
The Offering is being underwritten by Joseph Gunnar & Co., LLC (the "Underwriter") pursuant to an underwriting agreement dated November 19, 2026 between the Company and the Underwriter (the "Underwriting Agreement").
An investment in the Offered Shares involves risks that should be carefully considered by prospective investors before purchasing the Offered Shares. The risks outlined in this Prospectus Supplement, the accompanying Shelf Prospectus and in the documents incorporated by reference herein and therein should be carefully reviewed and considered by prospective investors in connection with any investment in the Offered Shares. See "Cautionary Note Regarding Forward-Looking Statements" and "Risk Factors".
THESE SECURITIES HAVE NOT BEEN APPROVED OR DISAPPROVED BY THE SEC OR ANY STATE SECURITIES COMMISSION OR ANY United States REGULATORY AUTHORITY NOR HAVE THESE AUTHORITIES PASSED UPON THE ACCURACY OR ADEQUACY OF THIS PROSPECTUS SUPPLEMENT. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
Prospective investors in the United States should be aware that this Offering is made by a foreign issuer that is permitted, under a multijurisdictional disclosure system adopted by the United States and Canada, to prepare this Prospectus Supplement and the accompanying Shelf Prospectus in accordance with the disclosure requirements of its home country. Prospective investors should be aware that such requirements are different from those of the United States. The financial statements included or incorporated herein have been prepared in accordance with IFRS® Accounting Standards ("IFRS") as issued by the International Accounting Standards Board and may be subject to foreign auditing and auditor independence standards, and thus may not be comparable to financial statements of United States companies.
Prospective investors should be aware that the acquisition of the Offered Shares described herein may have tax consequences both in the United States and in Canada. Such consequences may not be fully described herein. See "Certain Canadian Federal Income Tax Considerations" and "Certain United States Federal Income Tax Considerations".
The enforcement by investors of civil liabilities under United States federal securities laws may be affected adversely by the fact that the Company is incorporated under the laws of British Columbia, that some of its officers and directors may be residents of a foreign country, that some or all of the experts named in the Registration Statement may be residents of a foreign country, and that all or a substantial portion of the assets of the Company and said persons may be located outside the United States. See "Enforcement of Judgments Against Foreign Persons" and "Enforcement of Civil Liabilities".
Upon completion of the Offering and assuming no exercise of the Option to Purchase Additional Shares offered hereby and no other issuances of Common Shares, the Company's issued and outstanding Common Shares will consist of approximately 12,247,365 Common Shares. The foregoing assumes that the Share Consolidation described herein has become effective and gives effect to the Share Consolidation.
The Underwriter, as principal, may conditionally offer the Offered Shares qualified under this Prospectus Supplement and the Shelf Prospectus, subject to prior sale, if, as and when issued by the Company and accepted by the Underwriter in accordance with the conditions contained in the Underwriting Agreement, as described under "Plan of Distribution".
Certain legal matters relating to Canadian law with respect to the Offering will be passed upon on the Company's behalf by Bennett Jones LLP and on behalf of the Underwriter by Mintz LLP Certain legal matters relating to United States law with respect to the Offering will be passed upon on the Company's behalf by Alston & Bird LLP and on behalf of the Underwriter by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.
Subject to applicable laws, the Underwriter may, in connection with this Offering, over-allot or effect transactions that stabilize or maintain the market price of the Common Shares at levels other than those which might otherwise prevail on the open market. Such transactions, if commenced, may be discontinued at any time. After the Underwriter has made reasonable efforts to sell the Offered Shares at the Offering Price, the Underwriter may offer the Offered Shares to the public at prices lower than the Offering Price. Any such reduction will not affect the proceeds of this Offering to be received by the Company. See "Plan of Distribution".
Subscriptions will be received subject to rejection or allotment in whole or in part, and the right is reserved to close the subscription books at any time without notice. Closing of the Offering of the Offered Shares is expected to take place on or about November 23, 2026, or such earlier or later date as the Company and the Underwriter may agree (the "Closing Date").
It is expected that the Company will arrange for the instant deposit of the Common Shares offered hereby under the book-based system of registration, to be registered to The Depository Trust Company ("DTC") or its nominee and deposited with DTC on the Closing Date. No certificates evidencing the Offered Shares will be issued to purchasers. Purchasers will receive only a customer confirmation from the Underwriter or other registered dealer from or through which a beneficial interest in the Offered Shares is purchased. See "Plan of Distribution".
Our head office is located at 35 McCleary Court, Unit 21, Concord, Ontario L4K 3Y9, Canada, and our registered and records office is located at 550 Burrard Street, Suite 2300, Vancouver, British Columbia V6C 2B5, Canada. Our telephone number is (844)588-2088.
Underwriter
Joseph Gunnar & Co., LLC
Amended and Restated Offering Document under the Listed Issuer Financing Exemption
Document d'offre modifié et mis à jour sous le régime de la dispense pour financement del'émetteur coté